XML 100 R47.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK PROGRAMS (Tables)
12 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
Total net stock-based compensation expense is attributable to the granting of and the remaining requisite service periods of stock options, RSUs, PSUs, long-term PSUs and share units. Compensation expense attributable to net stock-based compensation is as follows:
Year Ended June 30
(In millions)202120202019
Compensation expense(1)
$327 $213 $243 
Income tax benefit$50 $41 $47 
(1)Excludes compensation expense relating to liability-classified awards, including DECIEM stock options discussed below.
Summary of stock option programs
The following is a summary of the Company’s stock option programs as of June 30, 2021 and changes during the fiscal year then ended:
(Shares in thousands)SharesWeighted-
Average
Exercise
Price Per Share
Aggregate
Intrinsic
Value(1)
(in millions)
Weighted-Average
Contractual Life
Remaining in Years
Outstanding at June 30, 2020
8,645.0 $108.30 
Granted at fair value1,542.0 218.95 
Exercised(2,459.0)87.50 
Expired(11.1)130.55 
Forfeited(101.7)192.96 
Outstanding at June 30, 2021
7,615.2 136.24 $1,385 6.0
Vested and expected to vest at June 30, 2021
7,547.9 135.58 $1,377 6.0
Exercisable at June 30, 2021
4,953.3 102.02 $1,070 5.0
(1)The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
The following is a summary of the DECIEM stock option program as of June 30, 2021 and changes during the fiscal year then ended:
(Shares in thousands)SharesWeighted-
Average
Exercise
Price Per Share
Aggregate
Intrinsic
Value(1)
(in millions)
Weighted-Average
Contractual Life
Remaining in Years
Outstanding at June 30, 2020
— $— 
Granted at fair value94.1 52.76 
Exercised— 
Expired— 
Forfeited— 
Outstanding at June 30, 2021
94.1 52.76 $145 2.9
Vested and expected to vest at June 30, 2021
91.0 54.54 $140 2.9
Exercisable at June 30, 2021
— — $— 
(1)The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
Summary of weighted-average grant date fair value and intrinsic value of stock options exercised
The following is a summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised:
Year Ended June 30
(In millions, except per share data)202120202019
Per-share weighted-average grant date fair value of stock options granted$54.83 $51.46 $38.62 
Intrinsic value of stock options exercised$407 $309 $283 
The following is a summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised:
Year Ended June 30
202120202019
Per-share weighted-average grant date fair value of stock options granted$1,557 $— $— 
Intrinsic value of stock options exercised$— $— $— 
Schedule of fair value option-pricing assumptions
The acquisition-date fair values of the DECIEM stock options and the net Put (Call) Option were calculated by incorporating significant assumptions including the starting equity value, revenue growth rates and EBITDA and the following key assumptions into the Monte Carlo Method:

May 18, 2021
Risk-free rate0.50%
Term to mid of last twelve-month period2.54 years
Operating leverage adjustment0.45
Net sales discount rate3.30%
EBITDA discount rate6.80%
EBITDA volatility38.30%
Net sales volatility17.20%
The fair value of each of the Company's option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
 Year Ended June 30
 202120202019
Weighted-average expected stock-price volatility26.1%25.1%24.5%
Weighted-average expected option life8 years7 years7 years
Average risk-free interest rate0.5%1.5%2.8%
Average dividend yield1.0%1.0%1.1%
The fair value of the stock options were calculated using the following key assumptions into the Monte Carlo Method:
 May 18, 2021June 30, 2021
Risk-free rate0.50%0.50%
Term to mid of last twelve-month period2.54 years2.42 years
Operating leverage adjustment0.450.45
Net sales discount rate3.30%3.40%
EBITDA discount rate6.80%6.90%
EBITDA volatility38.30%37.70%
Net sales volatility17.20%17.00%
Summary of restricted stock units (RSUs)
The following is a summary of the status of the Company’s RSUs as of June 30, 2021 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Nonvested at June 30, 2020
1,948.3 $157.89 
Granted984.0 220.04 
Dividend equivalents12.7 186.14 
Vested(989.7)145.53 
Forfeited(98.1)190.54 
Nonvested at June 30, 2021
1,857.2 195.77 
Summary of performance share units (PSUs)
The following is a summary of the status of the Company’s PSUs as of June 30, 2021 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Nonvested at June 30, 2020
695.1 $139.17 
Granted161.2 217.88 
Vested and issued(1)
— — 
Forfeited(56.2)92.18 
Nonvested at June 30, 2021
800.1 158.33 
(1) Approximately 0.2 million PSUs with a performance period ended June 30, 2021 to be issued in September 2021 are included in Nonvested at June 30, 2021.
Schedule of long-term price vested units The number of shares subject to each tranche of the price-vested unit award, as well as the stock price goals, service periods, performance periods and share delivery dates for each tranche are as follows:
Number
of
Shares
per
Tranche
Stock Price Goal
(per Share)
Service PeriodPerformance Period for Stock Price GoalPerformance Period for Cumulative Operating Income GoalShare Delivery Date
First tranche27,457 $323.03 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Second tranche28,598 $333.21 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Third tranche29,872 $343.61 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Total shares85,927 
Schedule of assumptions used for award The significant assumptions used for this award were as follows:
Expected volatility31.8 %
Dividend yield0.8 %
Risk-free interest rate0.4 %
Expected term3.3 years
Summary of status of share units
The following is a summary of the status of the Company’s share units as of June 30, 2021 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Outstanding at June 30, 2020136.8 $62.46 
Granted3.6 246.82 
Dividend equivalents1.2 262.37 
Outstanding at June 30, 2021141.6 68.73